01-10-2013 | Letter to the Editor
Gratifying clinical experience with an indigenously formulated single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical division of BARC: a pivotal boost for building up a peptide receptor radionuclide therapy programme in an Indian setting
Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 10/2013
Login to get access